Trial results for a study investigating Accelerated Transcranial Magnetic Stimulation (TMS) for smoking cessation in people living with HIV/AIDS (PLWHA) were posted on ClinicalTrials.gov on 2025-10-22. The study enrolled 4 participants.

Background

People living with HIV (PLWH) often face a higher prevalence of tobacco smoking compared to the general population, which exacerbates existing health challenges and complicates HIV management. Smoking cessation is a critical health goal for PLWH, but traditional methods may have limited efficacy in this group due to various psychosocial and biological factors. Transcranial Magnetic Stimulation (TMS), a non-invasive brain stimulation technique, has been explored as a potential intervention for addiction, including smoking cessation, by modulating neural circuits associated with craving and attentional bias towards smoking cues. Investigating such interventions is important for addressing the specific needs of PLWH who smoke.

Trial design

This completed study, designated as Phase NA, enrolled 4 participants with conditions including HIV and Tobacco Smoking. The trial aimed to demonstrate whether four sessions of Theta Burst Stimulation (TBS), a form of accelerated TMS, could improve attentional bias and craving in PLWHA smokers compared to four sessions of sham stimulation. The intervention involved TBS applied to the left dorsolateral prefrontal cortex (DLPFC). The hypothesis was that TBS would significantly improve attentional bias and craving for smoking cues compared to neutral cues, relative to sham stimulation.

Key results

The trial reported several key measurements related to gaze fixation on smoking cues, craving for cigarettes, and functional connectivity changes:

What this means

The posted results provide preliminary data on the effects of accelerated TMS on attentional bias and craving in a small cohort of HIV-positive smokers. Given the enrollment of only 4 participants, these findings are exploratory and should be interpreted with caution. The measurements offer initial insights into how TBS might influence specific markers related to smoking behavior in this vulnerable population. However, without statistical analyses or larger sample sizes, no definitive conclusions about the efficacy or comparative benefits of TBS versus sham stimulation can be drawn. These results may inform the design of future, larger-scale studies.

Source

The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT05295953, titled "Accelerated Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)", were posted on 2025-10-22 on clinicaltrials.gov.